Clinical Trials · NCT05129891
A Research Study Looking at New Protein-based Tablets in Healthy Male Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 384
- Start date
- Nov 2021
- Locations
- 2 sites, Canada, Germany
- Primary endpoint
- AUC0-24h,API,day10; area under the API plasma concentration-time curve from 0 to 24 hours after the 10th dose